Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Alternative RNA Splicing02:18

Alternative RNA Splicing

21.7K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.7K
RNA Splicing01:32

RNA Splicing

56.9K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

7.2K
In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
7.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Bioinspired electrochemical artificial muscles with low voltage redox triggering and spontaneous contraction.

Nature communications·2026
Same author

AQP1 Suppresses Clear Cell Renal Cell Carcinoma via Epigenetic Silencing and TNF-Mediated Apoptosis.

International journal of molecular sciences·2026
Same author

Heart Failure Medication Withdrawal in Patients With Improved Cardiac Function After Atrial Fibrillation Ablation: The DEFINITION-AF Pilot Randomized Clinical Trial.

JAMA network open·2026
Same author

Endometrial receptivity characteristics in patients with repeated implantation failure: a study using LASSO regression and Bayesian generalized linear model analysis.

Frontiers in medicine·2026
Same author

Empagliflozin-pirfenidone dual therapy improves cardiac function and structure in a preclinical two-hit HFpEF model.

Frontiers in pharmacology·2026
Same author

Controlled assembly of two-dimensional porphyrin heterostructures toward directed energy transfer and charge separation.

Nature communications·2026

相关实验视频

Updated: Sep 9, 2025

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.0K

H3K18la促进STIL的TRA2A介导替代分离,抑制卵巢癌中的铁和西斯治疗敏感性

Mingyang Gao1, Shiming Wang2, Zhiyuan Huang3

  • 1General Hospital of Northern Theater Command, Shenyang, China.

Cancer research and treatment
|September 4, 2025
PubMed
概括
此摘要是机器生成的。

卵巢癌细胞通过TRA2A-STIL信号通路逃避细胞死亡,由基因素乳化驱动. 准这种途径可以提高化疗的有效性,

关键词:
替代拼接铁症H3K18la 其他卵巢瘤在TRA2A

更多相关视频

Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells
11:11

Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells

Published on: April 25, 2018

8.3K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.8K

相关实验视频

Last Updated: Sep 9, 2025

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.0K
Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells
11:11

Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells

Published on: April 25, 2018

8.3K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.8K

科学领域:

  • 癌症学
  • 分子生物学
  • 表观遗传学

背景情况:

  • 由于晚期诊断和化学抵抗,卵巢癌 (OC) 面临重大挑战.
  • 了解OC的发展机制和确定新的治疗点至关重要.

研究的目的:

  • 阐明TRA2A和基因素乳化在OC进展中的作用.
  • 确定克服OC化学抵抗的新疗法目标.

主要方法:

  • 生物信息学分析,qRT-PCR,西部血块 (WB) 和免疫组织化学 (IHC) 检测TRA2A和基因素乳化.
  • 细胞增殖试验 (CCK8,克隆形成,EDU) 和Transwell试验.
  • 用裸体老鼠异种移植模型进行RT-PCR替代拼接分析和体内验证.

主要成果:

  • 通过TRA2A-STIL信号轴确定了OC铁脱离的新机制.
  • 基因组乳化 (H3K18la) 促进TRA2A转录,导致STIL mRNA替代拼接和STIL-L异型.
  • 针对性TRA2A抑制与西斯普拉丁治疗增强了OC疗效.

结论:

  • OC细胞通过H3K18la修饰的TRA2A-STIL信号轴避开铁.
  • 针对TRA2A介导的替代拼接是一种有前途的卵巢癌治疗策略.